Category: IBBJ

Defiance Debuts Nasdaq Junior Biotechnology ETF (IBBJ)

Defiance ETFs debuted a new ETF today with targeted exposure to the junior disruptors in the biotech space.

Defiance ETFs LLC announced the launch of the Defiance Nasdaq Junior Biotechnology ETF (IBBJ), which tracks the Nasdaq Junior Biotechnology Index, offering investors exposure to “junior” companies with a market capitalization below $5 billion.

“At Defiance, we believe in providing the next generation of investors with targeted exposure to disruptive themes. IBBJ does just that, offering exposure to the junior disruptors in the biotech space, and allowing investors to express either a short- or long-term view,” said Matt Bielski, Chief Executive Officer at Defiance ETFs.

Cameron Lilja, Vice President and Head of Index Research and Development for Nasdaq Global Indexes, said...

Read more at etftrends.com

Want to work with us?

A wonderful serenity has taken possession of my entire soul, like these sweet mornings of spring which I enjoy with my whole heart. I am alone, and feel the charm of existence in this spot.

Contact us